5Germing U,Gattermann N,Strupp C,et al.Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes:a retrospective analysis of 1600 patients.Leuk Res,2000,24(12):983～992. 被引量：1
二级参考文献1
1J. M. Hernández,M. C. del Ca?izo,A. Cuneo,J. L. García,N. C. Gutiérrez,M. González,G. Castoldi,J. F. San Miguel. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia[J] 2000,Annals of Oncology(4):441～444 被引量：1
2[2]Vardiman JW,Harris NL,Brunning RD.The world Health Organization(WHO)classification of the myeloid neoplasms[J].Blood,2002,100(7):2292 被引量：1
3[4]Jonasova A,Neuwirtova R,CermakJ.Cyelosporina therap in hypoplastic MDS patients and Cartain refractory anemia without hypaplastic bone marrow[J].Br J Haematol,1998,100(2):304 被引量：1
4Vardiman JW,Harris NL,Brunning RD.The world Health Organization(WHO) classification of the myeloid neoplasms[J].Blood,2002,100(7):2292. 被引量：1
5Jonasova A,Neuwirtova R,Cermak J.Cyclosporin2atherapy in hypoplastic MDS patients and Cartain refractory anemias without hypaplastic bone marrow[J].Br J Haematol,1998,100 (2):304. 被引量：1
